CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis:

Background:Interventions targeting the adaptive immune response are needed in multiple sclerosis (MS).Objective:Evaluate laquinimod’s efficacy, safety, and tolerability in patients with relapsing-r...